| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA-Directed RNA Polymerases | 8 | 2021 | 103 | 4.280 |
Why?
|
| Biosensing Techniques | 8 | 2024 | 73 | 3.840 |
Why?
|
| Fluorescent Dyes | 13 | 2021 | 243 | 3.170 |
Why?
|
| RNA | 6 | 2024 | 578 | 2.980 |
Why?
|
| Mitochondria | 11 | 2021 | 553 | 2.310 |
Why?
|
| Protein Interaction Mapping | 4 | 2021 | 82 | 2.140 |
Why?
|
| Protein Processing, Post-Translational | 10 | 2024 | 382 | 2.130 |
Why?
|
| Hydrogen Peroxide | 11 | 2021 | 159 | 2.000 |
Why?
|
| Transcriptome | 6 | 2023 | 628 | 1.830 |
Why?
|
| RNA, Messenger | 5 | 2024 | 2011 | 1.750 |
Why?
|
| Lipoylation | 12 | 2024 | 30 | 1.740 |
Why?
|
| CRISPR-Cas Systems | 5 | 2022 | 77 | 1.670 |
Why?
|
| Esterases | 3 | 2024 | 13 | 1.630 |
Why?
|
| Adenosine | 3 | 2019 | 237 | 1.620 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 4 | 2023 | 196 | 1.580 |
Why?
|
| Gene Editing | 3 | 2022 | 47 | 1.450 |
Why?
|
| Thiolester Hydrolases | 6 | 2020 | 14 | 1.250 |
Why?
|
| HEK293 Cells | 13 | 2024 | 638 | 1.250 |
Why?
|
| Acyltransferases | 3 | 2022 | 41 | 1.210 |
Why?
|
| Peptide Hydrolases | 3 | 2021 | 101 | 1.180 |
Why?
|
| Evolution, Molecular | 4 | 2021 | 839 | 1.170 |
Why?
|
| Cysteine | 5 | 2024 | 136 | 1.140 |
Why?
|
| Piperazines | 3 | 2021 | 283 | 1.070 |
Why?
|
| Protein Engineering | 4 | 2019 | 141 | 1.050 |
Why?
|
| Signal Transduction | 10 | 2024 | 3373 | 1.040 |
Why?
|
| Gene Expression Profiling | 2 | 2023 | 1429 | 1.020 |
Why?
|
| High-Throughput Screening Assays | 3 | 2022 | 58 | 1.010 |
Why?
|
| Proteins | 5 | 2024 | 786 | 0.990 |
Why?
|
| Bacteriophage T7 | 3 | 2020 | 7 | 0.970 |
Why?
|
| Mutation | 8 | 2021 | 4132 | 0.960 |
Why?
|
| Synthetic Biology | 2 | 2021 | 15 | 0.960 |
Why?
|
| Viral Proteins | 4 | 2020 | 301 | 0.950 |
Why?
|
| Luminescent Measurements | 1 | 2024 | 62 | 0.940 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2024 | 45 | 0.940 |
Why?
|
| Protein Biosynthesis | 2 | 2023 | 388 | 0.920 |
Why?
|
| Gene Expression Regulation | 4 | 2023 | 1975 | 0.910 |
Why?
|
| Molecular Imaging | 4 | 2015 | 65 | 0.880 |
Why?
|
| Staining and Labeling | 2 | 2024 | 168 | 0.850 |
Why?
|
| Escherichia coli | 3 | 2021 | 605 | 0.850 |
Why?
|
| MAP Kinase Signaling System | 1 | 2023 | 197 | 0.850 |
Why?
|
| Peroxiredoxins | 2 | 2019 | 13 | 0.840 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 2 | 2023 | 37 | 0.830 |
Why?
|
| Nucleic Acids | 1 | 2022 | 32 | 0.800 |
Why?
|
| Oligonucleotides | 1 | 2022 | 92 | 0.790 |
Why?
|
| Protein Transport | 3 | 2021 | 421 | 0.770 |
Why?
|
| CRISPR-Associated Proteins | 2 | 2018 | 5 | 0.760 |
Why?
|
| Microscopy, Fluorescence | 8 | 2021 | 428 | 0.750 |
Why?
|
| Escherichia coli Proteins | 1 | 2021 | 183 | 0.700 |
Why?
|
| Humans | 48 | 2024 | 89063 | 0.700 |
Why?
|
| HIV Reverse Transcriptase | 1 | 2019 | 14 | 0.690 |
Why?
|
| Transcription Activator-Like Effector Nucleases | 1 | 2019 | 1 | 0.680 |
Why?
|
| Bacteriophages | 1 | 2019 | 51 | 0.670 |
Why?
|
| RNA Editing | 1 | 2019 | 35 | 0.660 |
Why?
|
| RNA-Binding Proteins | 2 | 2018 | 258 | 0.640 |
Why?
|
| Antiviral Agents | 5 | 2022 | 475 | 0.640 |
Why?
|
| Spiro Compounds | 2 | 2021 | 25 | 0.630 |
Why?
|
| Reactive Oxygen Species | 3 | 2016 | 490 | 0.620 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2018 | 40 | 0.620 |
Why?
|
| Molecular Structure | 6 | 2024 | 289 | 0.620 |
Why?
|
| Homeostasis | 2 | 2019 | 413 | 0.620 |
Why?
|
| Acylation | 5 | 2024 | 40 | 0.620 |
Why?
|
| Intravital Microscopy | 1 | 2017 | 11 | 0.600 |
Why?
|
| Carbamates | 1 | 2017 | 15 | 0.600 |
Why?
|
| Mitochondrial Proteins | 1 | 2019 | 127 | 0.600 |
Why?
|
| Endonucleases | 1 | 2017 | 23 | 0.600 |
Why?
|
| Animals | 26 | 2024 | 27317 | 0.590 |
Why?
|
| Protein Interaction Maps | 1 | 2017 | 49 | 0.580 |
Why?
|
| Protease Inhibitors | 3 | 2024 | 73 | 0.550 |
Why?
|
| HeLa Cells | 6 | 2023 | 511 | 0.540 |
Why?
|
| Hepatitis C | 1 | 2018 | 170 | 0.540 |
Why?
|
| DNA | 1 | 2022 | 1307 | 0.540 |
Why?
|
| Electron Transport Complex III | 1 | 2015 | 13 | 0.530 |
Why?
|
| Oxidation-Reduction | 6 | 2019 | 387 | 0.520 |
Why?
|
| Free Radical Scavengers | 1 | 2015 | 59 | 0.520 |
Why?
|
| Superoxides | 1 | 2015 | 74 | 0.520 |
Why?
|
| Drug Resistance, Viral | 1 | 2014 | 48 | 0.490 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 506 | 0.490 |
Why?
|
| Pyrazoles | 1 | 2015 | 150 | 0.480 |
Why?
|
| Genetic Techniques | 1 | 2014 | 73 | 0.470 |
Why?
|
| Hepacivirus | 1 | 2014 | 129 | 0.450 |
Why?
|
| Diagnostic Imaging | 1 | 2017 | 479 | 0.450 |
Why?
|
| Fear | 2 | 2023 | 79 | 0.440 |
Why?
|
| Pyrimidines | 1 | 2015 | 372 | 0.430 |
Why?
|
| Adaptation, Biological | 1 | 2013 | 85 | 0.410 |
Why?
|
| RNA, Long Noncoding | 2 | 2023 | 117 | 0.410 |
Why?
|
| Models, Molecular | 5 | 2021 | 1296 | 0.410 |
Why?
|
| Mice | 13 | 2024 | 11737 | 0.390 |
Why?
|
| Bacterial Proteins | 1 | 2017 | 887 | 0.380 |
Why?
|
| Lipids | 2 | 2023 | 271 | 0.350 |
Why?
|
| RNA Processing, Post-Transcriptional | 3 | 2022 | 111 | 0.340 |
Why?
|
| Luciferases | 2 | 2024 | 128 | 0.340 |
Why?
|
| Stress, Physiological | 1 | 2011 | 229 | 0.340 |
Why?
|
| Gene Knockdown Techniques | 3 | 2019 | 247 | 0.320 |
Why?
|
| Mammals | 2 | 2023 | 235 | 0.320 |
Why?
|
| Directed Molecular Evolution | 2 | 2022 | 20 | 0.310 |
Why?
|
| Epistasis, Genetic | 2 | 2021 | 90 | 0.290 |
Why?
|
| Fluorescence | 2 | 2019 | 103 | 0.280 |
Why?
|
| Boronic Acids | 3 | 2013 | 56 | 0.270 |
Why?
|
| Virus Replication | 4 | 2022 | 321 | 0.270 |
Why?
|
| Cyclization | 1 | 2024 | 11 | 0.240 |
Why?
|
| Macrocyclic Compounds | 1 | 2024 | 8 | 0.240 |
Why?
|
| Promoter Regions, Genetic | 4 | 2023 | 956 | 0.240 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2024 | 10 | 0.240 |
Why?
|
| Pyroptosis | 1 | 2024 | 4 | 0.240 |
Why?
|
| Sulfones | 1 | 2024 | 45 | 0.240 |
Why?
|
| Luminescence | 1 | 2024 | 21 | 0.240 |
Why?
|
| Peptides, Cyclic | 1 | 2024 | 44 | 0.240 |
Why?
|
| Sulfides | 1 | 2024 | 68 | 0.240 |
Why?
|
| Cell Survival | 3 | 2021 | 982 | 0.230 |
Why?
|
| Base Sequence | 3 | 2019 | 2327 | 0.230 |
Why?
|
| Protein Binding | 4 | 2023 | 1487 | 0.230 |
Why?
|
| Gene Expression | 2 | 2021 | 1310 | 0.230 |
Why?
|
| Internal Ribosome Entry Sites | 1 | 2023 | 16 | 0.230 |
Why?
|
| Oncolytic Viruses | 1 | 2023 | 24 | 0.220 |
Why?
|
| Drug Discovery | 1 | 2024 | 107 | 0.220 |
Why?
|
| Epidermal Growth Factor | 1 | 2023 | 117 | 0.220 |
Why?
|
| Cell Movement | 3 | 2018 | 783 | 0.220 |
Why?
|
| Oncolytic Virotherapy | 1 | 2023 | 42 | 0.220 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2023 | 123 | 0.220 |
Why?
|
| Phosphorylation | 2 | 2023 | 1130 | 0.220 |
Why?
|
| Tuberculosis | 1 | 2024 | 121 | 0.210 |
Why?
|
| RNA Interference | 2 | 2021 | 376 | 0.210 |
Why?
|
| Methylation | 1 | 2023 | 268 | 0.210 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 2022 | 8 | 0.210 |
Why?
|
| Cannabidiol | 1 | 2022 | 7 | 0.210 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2023 | 198 | 0.200 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2024 | 387 | 0.200 |
Why?
|
| Catalysis | 1 | 2022 | 205 | 0.200 |
Why?
|
| Ethylamines | 1 | 2021 | 2 | 0.200 |
Why?
|
| Coronavirus OC43, Human | 1 | 2021 | 7 | 0.200 |
Why?
|
| CD36 Antigens | 1 | 2021 | 13 | 0.200 |
Why?
|
| Acrylamides | 1 | 2021 | 32 | 0.200 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2021 | 53 | 0.190 |
Why?
|
| Papain | 1 | 2021 | 6 | 0.190 |
Why?
|
| Maleimides | 1 | 2021 | 26 | 0.190 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2021 | 86 | 0.190 |
Why?
|
| Up-Regulation | 1 | 2023 | 727 | 0.190 |
Why?
|
| Thiazoles | 1 | 2021 | 128 | 0.180 |
Why?
|
| Gene Duplication | 1 | 2021 | 126 | 0.180 |
Why?
|
| Brain | 1 | 2010 | 2281 | 0.180 |
Why?
|
| Vascular Remodeling | 1 | 2020 | 22 | 0.180 |
Why?
|
| Host-Pathogen Interactions | 1 | 2022 | 236 | 0.170 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2019 | 43 | 0.170 |
Why?
|
| Hippocampus | 1 | 2023 | 447 | 0.170 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 557 | 0.170 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 179 | 0.170 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2010 | 85 | 0.170 |
Why?
|
| Islets of Langerhans | 1 | 2023 | 548 | 0.170 |
Why?
|
| ras Proteins | 1 | 2020 | 130 | 0.170 |
Why?
|
| Molecular Sequence Data | 2 | 2014 | 3027 | 0.170 |
Why?
|
| Parkinson Disease | 1 | 2021 | 146 | 0.160 |
Why?
|
| Insulin-Secreting Cells | 1 | 2023 | 404 | 0.160 |
Why?
|
| Indoles | 1 | 2021 | 312 | 0.160 |
Why?
|
| Peripheral Arterial Disease | 1 | 2020 | 94 | 0.160 |
Why?
|
| Proteolysis | 1 | 2019 | 108 | 0.160 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2018 | 243 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 2 | 2018 | 1057 | 0.160 |
Why?
|
| Wnt-5a Protein | 1 | 2018 | 10 | 0.160 |
Why?
|
| Immunity, Innate | 1 | 2022 | 429 | 0.160 |
Why?
|
| Cell Membrane | 1 | 2021 | 668 | 0.160 |
Why?
|
| Enzyme Inhibitors | 1 | 2021 | 645 | 0.160 |
Why?
|
| Cloning, Molecular | 1 | 2019 | 646 | 0.150 |
Why?
|
| Propiolactone | 1 | 2017 | 1 | 0.150 |
Why?
|
| Activation, Metabolic | 1 | 2017 | 1 | 0.150 |
Why?
|
| Xanthones | 1 | 2017 | 11 | 0.150 |
Why?
|
| Palmitates | 1 | 2017 | 15 | 0.150 |
Why?
|
| Endopeptidases | 1 | 2018 | 117 | 0.150 |
Why?
|
| Computers, Molecular | 1 | 2017 | 2 | 0.150 |
Why?
|
| Abscisic Acid | 1 | 2017 | 5 | 0.150 |
Why?
|
| Reproducibility of Results | 4 | 2022 | 2752 | 0.150 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 497 | 0.150 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2017 | 13 | 0.150 |
Why?
|
| Logic | 1 | 2017 | 11 | 0.150 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2024 | 575 | 0.150 |
Why?
|
| Biomarkers | 1 | 2024 | 1755 | 0.150 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 82 | 0.150 |
Why?
|
| Transfection | 1 | 2019 | 911 | 0.150 |
Why?
|
| Mitochondrial Dynamics | 1 | 2018 | 56 | 0.150 |
Why?
|
| Protein Domains | 1 | 2017 | 133 | 0.140 |
Why?
|
| Solubility | 1 | 2017 | 179 | 0.140 |
Why?
|
| Metalloporphyrins | 1 | 2016 | 26 | 0.140 |
Why?
|
| Epithelial Cells | 2 | 2022 | 688 | 0.140 |
Why?
|
| Structure-Activity Relationship | 1 | 2017 | 412 | 0.140 |
Why?
|
| Selenoproteins | 1 | 2016 | 20 | 0.140 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2018 | 565 | 0.140 |
Why?
|
| A549 Cells | 3 | 2022 | 41 | 0.140 |
Why?
|
| Thioredoxins | 1 | 2016 | 13 | 0.140 |
Why?
|
| Macrophages | 2 | 2010 | 571 | 0.130 |
Why?
|
| Water | 1 | 2017 | 283 | 0.130 |
Why?
|
| Cell Line | 3 | 2019 | 2495 | 0.130 |
Why?
|
| Optical Imaging | 2 | 2013 | 50 | 0.130 |
Why?
|
| Cell Line, Tumor | 4 | 2021 | 2552 | 0.130 |
Why?
|
| Phylogeny | 1 | 2021 | 1182 | 0.130 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2016 | 111 | 0.130 |
Why?
|
| Microscopy, Electron | 1 | 2015 | 510 | 0.130 |
Why?
|
| Bacteriophage M13 | 1 | 2014 | 9 | 0.120 |
Why?
|
| Isoindoles | 1 | 2014 | 14 | 0.120 |
Why?
|
| Lactams | 1 | 2014 | 11 | 0.120 |
Why?
|
| Lactams, Macrocyclic | 1 | 2014 | 14 | 0.120 |
Why?
|
| Cyclopropanes | 1 | 2014 | 25 | 0.120 |
Why?
|
| Oxidative Stress | 3 | 2016 | 458 | 0.120 |
Why?
|
| Proline | 1 | 2014 | 55 | 0.120 |
Why?
|
| Isoquinolines | 1 | 2014 | 72 | 0.120 |
Why?
|
| Carcinogenesis | 1 | 2016 | 211 | 0.120 |
Why?
|
| Staphylococcus aureus | 1 | 2017 | 275 | 0.120 |
Why?
|
| Neurons | 1 | 2023 | 1580 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 1176 | 0.120 |
Why?
|
| Cell Proliferation | 2 | 2018 | 1650 | 0.110 |
Why?
|
| Extinction, Psychological | 2 | 2023 | 19 | 0.110 |
Why?
|
| Melanoma | 1 | 2018 | 467 | 0.110 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2016 | 412 | 0.110 |
Why?
|
| Fluorescein | 2 | 2010 | 16 | 0.110 |
Why?
|
| Microscopy, Confocal | 2 | 2018 | 277 | 0.110 |
Why?
|
| Stochastic Processes | 1 | 2013 | 77 | 0.110 |
Why?
|
| Endoplasmic Reticulum | 2 | 2012 | 255 | 0.110 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 1157 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2013 | 283 | 0.110 |
Why?
|
| STAT5 Transcription Factor | 1 | 2012 | 43 | 0.100 |
Why?
|
| Sulfonamides | 1 | 2014 | 317 | 0.100 |
Why?
|
| DNA Primers | 1 | 2013 | 543 | 0.100 |
Why?
|
| Time Factors | 1 | 2021 | 5320 | 0.100 |
Why?
|
| DNA, Viral | 1 | 2013 | 261 | 0.100 |
Why?
|
| NADPH Oxidases | 1 | 2012 | 82 | 0.100 |
Why?
|
| Vero Cells | 2 | 2022 | 102 | 0.100 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2012 | 131 | 0.100 |
Why?
|
| DNA Mutational Analysis | 1 | 2013 | 529 | 0.100 |
Why?
|
| Cells, Cultured | 1 | 2017 | 2880 | 0.100 |
Why?
|
| Electron Transport | 1 | 2011 | 74 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 2 | 2012 | 740 | 0.100 |
Why?
|
| Molecular Docking Simulation | 2 | 2021 | 49 | 0.090 |
Why?
|
| Catalytic Domain | 2 | 2021 | 156 | 0.090 |
Why?
|
| Synapses | 2 | 2023 | 278 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 921 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2016 | 1265 | 0.090 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 2062 | 0.090 |
Why?
|
| Amino Acids | 1 | 2011 | 245 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 1241 | 0.090 |
Why?
|
| Color | 1 | 2010 | 85 | 0.090 |
Why?
|
| Polyubiquitin | 1 | 2009 | 8 | 0.090 |
Why?
|
| Molecular Weight | 1 | 2009 | 331 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2013 | 481 | 0.080 |
Why?
|
| Protein Folding | 1 | 2011 | 287 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2010 | 181 | 0.080 |
Why?
|
| Ubiquitin | 1 | 2009 | 96 | 0.080 |
Why?
|
| Circadian Rhythm | 1 | 2011 | 305 | 0.080 |
Why?
|
| Cricetulus | 1 | 2008 | 126 | 0.080 |
Why?
|
| COS Cells | 1 | 2008 | 167 | 0.080 |
Why?
|
| CHO Cells | 1 | 2008 | 187 | 0.080 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2008 | 95 | 0.080 |
Why?
|
| Cricetinae | 1 | 2008 | 558 | 0.070 |
Why?
|
| Cell Culture Techniques | 2 | 2021 | 192 | 0.070 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2009 | 285 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2023 | 1237 | 0.070 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2012 | 788 | 0.070 |
Why?
|
| Male | 5 | 2023 | 42251 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 2411 | 0.060 |
Why?
|
| Inflammasomes | 1 | 2024 | 26 | 0.060 |
Why?
|
| Binding Sites | 2 | 2021 | 1117 | 0.060 |
Why?
|
| Vaccinia virus | 1 | 2023 | 19 | 0.060 |
Why?
|
| Protein Multimerization | 2 | 2018 | 175 | 0.050 |
Why?
|
| Vesicular Transport Proteins | 1 | 2023 | 63 | 0.050 |
Why?
|
| Rats | 2 | 2023 | 4040 | 0.050 |
Why?
|
| Prefrontal Cortex | 1 | 2023 | 134 | 0.050 |
Why?
|
| Virus Internalization | 1 | 2022 | 39 | 0.050 |
Why?
|
| Cytosol | 1 | 2022 | 193 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2023 | 446 | 0.050 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2021 | 64 | 0.050 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2022 | 85 | 0.050 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2022 | 91 | 0.050 |
Why?
|
| Kinetics | 2 | 2018 | 1528 | 0.050 |
Why?
|
| Interferons | 1 | 2022 | 124 | 0.050 |
Why?
|
| Polyproteins | 1 | 2021 | 3 | 0.050 |
Why?
|
| Endoribonucleases | 1 | 2022 | 92 | 0.050 |
Why?
|
| Drug Repositioning | 1 | 2021 | 23 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2021 | 149 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2021 | 105 | 0.050 |
Why?
|
| Viral Load | 1 | 2021 | 145 | 0.050 |
Why?
|
| Thermodynamics | 1 | 2021 | 311 | 0.050 |
Why?
|
| RNA, Transfer | 1 | 2022 | 159 | 0.040 |
Why?
|
| Benzamides | 1 | 2021 | 237 | 0.040 |
Why?
|
| Cytokines | 1 | 2024 | 802 | 0.040 |
Why?
|
| Learning | 1 | 2023 | 285 | 0.040 |
Why?
|
| Models, Biological | 2 | 2021 | 1763 | 0.040 |
Why?
|
| Piperidines | 1 | 2021 | 164 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2021 | 352 | 0.040 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2020 | 68 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2021 | 332 | 0.040 |
Why?
|
| Glucose | 1 | 2023 | 630 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2021 | 255 | 0.040 |
Why?
|
| Female | 3 | 2022 | 46011 | 0.040 |
Why?
|
| Pyridines | 1 | 2021 | 315 | 0.040 |
Why?
|
| CD146 Antigen | 1 | 2018 | 4 | 0.040 |
Why?
|
| Hyaluronan Receptors | 1 | 2018 | 38 | 0.040 |
Why?
|
| Acyl Coenzyme A | 1 | 2018 | 17 | 0.040 |
Why?
|
| ErbB Receptors | 1 | 2021 | 500 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2023 | 1990 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2018 | 114 | 0.040 |
Why?
|
| Insulin | 1 | 2023 | 1146 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 1574 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2022 | 657 | 0.040 |
Why?
|
| Catalase | 1 | 2016 | 49 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 1940 | 0.030 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2016 | 29 | 0.030 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2016 | 48 | 0.030 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2016 | 68 | 0.030 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2016 | 43 | 0.030 |
Why?
|
| Apoptosis | 1 | 2023 | 1716 | 0.030 |
Why?
|
| Selenium | 1 | 2016 | 46 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 576 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2019 | 465 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 155 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2022 | 1215 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2018 | 887 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2016 | 284 | 0.030 |
Why?
|
| Chemistry Techniques, Synthetic | 1 | 2015 | 9 | 0.030 |
Why?
|
| Models, Chemical | 1 | 2016 | 179 | 0.030 |
Why?
|
| Molecular Probes | 1 | 2015 | 35 | 0.030 |
Why?
|
| DNA Damage | 1 | 2016 | 371 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2013 | 38 | 0.030 |
Why?
|
| Zebrafish | 1 | 2016 | 319 | 0.030 |
Why?
|
| Prostate | 1 | 2016 | 393 | 0.030 |
Why?
|
| Benzoxazoles | 1 | 2012 | 4 | 0.030 |
Why?
|
| Mutation Rate | 1 | 2013 | 48 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 1 | 2012 | 10 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2012 | 44 | 0.030 |
Why?
|
| Staurosporine | 1 | 2012 | 33 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2012 | 69 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2012 | 106 | 0.030 |
Why?
|
| Triazoles | 1 | 2012 | 102 | 0.020 |
Why?
|
| Imidazoles | 1 | 2012 | 148 | 0.020 |
Why?
|
| Pyrroles | 1 | 2012 | 187 | 0.020 |
Why?
|
| Child | 1 | 2022 | 7149 | 0.020 |
Why?
|
| Fluorescence Polarization | 1 | 2009 | 8 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2009 | 47 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2009 | 146 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 269 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2009 | 112 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2013 | 509 | 0.020 |
Why?
|
| Lysine | 1 | 2009 | 150 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2009 | 312 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 604 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2013 | 944 | 0.020 |
Why?
|